Numaferm

Developer of recombinant antimicrobial and adhesive peptides

placeDusseldorf, North Rhine Westphalia, Germany calendar_todayFounded 2017 groups11 employees language numaferm.com

Registered entities

Innovation

9 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 263 times.

YearFilings
20171
20182
20192
20213
20222
20232
20243
20253
20261

Social engagement

Social engagement: 7.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Evonik, Evonik Venture Capital, European Investment Fund, HTGF.

Investor typeCountShare
Venture capital220%
Private equity110%
Accelerator & incubator110%
Other / undisclosed660%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

22 May 2026 · Marketing Manager

4 Dec 2024 · CTA (m/w/d) · Essen

Based on job postings tracked across public sources.

Recent activity

2 Jun 2026
Event
Bio:cap, the Life Science and AI Investival
29 May 2026
Event
BIO2026
13 May 2026
Event
PEGSBoston
Coming soon